Votrient 400 mg, Filmtabletten

7680603260020 CH-60326 Filmtabletten
Votrient 400 mg, Filmtabletten
Votrient 400 mg, Filmtabletten
Votrient 400 mg, Filmtabletten
1 / 3
google

Article details

Package size
60
Selling units
60
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
01/10/2021
Summary of Product Characteristics
Français
01/10/2021
Summary of Product Characteristics
Italien
01/10/2021
Patient information leaflet
Allemand
28/09/2021
Patient information leaflet
Français
28/09/2021
Patient information leaflet
Italien
28/09/2021

Detailed composition

Substance Quantity Type Category
(N/A)
400.0 MG Substance Wirkstoff (Principe actif)
(N/A)
433.4 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
1.8 MG Substance HBESI

Reimbursement information

Public price
CHF 3511.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2010

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
60326
Drug name
Votrient, Filmtabletten
Galenic form
FILM
ATC Code
L01XE11
Authorization status
Z
Dispensing category
A
First authorization
27/08/2010
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Behandlung des Nierenzellkarzinoms Behandlung des fortgeschrittenen Weichteilsarkoms

Package details

Description (FR)
VOTRIENT cpr pell 400 mg bte 60 pce
Description (DE)
VOTRIENT Filmtabl 400 mg Ds 60 Stk
Market launch
27/08/2010
Narcotic (BTM)
No

Other package sizes (1)

VOTRIENT cpr pell 200 mg bte 30 pce
30 TABL
GTIN: 7680603260013
View